Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium

被引:71
|
作者
Rudolph, Anja [1 ,2 ]
Song, Minsun [3 ]
Brook, Mark N. [4 ]
Milne, Roger L. [5 ,6 ]
Mavaddat, Nasim [7 ]
Michailidou, Kyriaki [7 ,8 ]
Bolla, Manjeet K. [7 ]
Wang, Qin [7 ]
Dennis, Joe [7 ]
Wilcox, Amber N. [9 ]
Hopper, John L. [6 ]
Southey, Melissa C. [10 ]
Keeman, Renske [11 ]
Fasching, Peter A. [12 ,13 ]
Beckmann, Matthias W. [12 ]
Gago-Dominguez, Manuela [14 ,15 ]
Castelao, Jose E. [16 ]
Guenel, Pascal [17 ]
Truong, Therese [17 ]
Bojesen, Stig E. [18 ,19 ,20 ]
Flyger, Henrik [21 ]
Brenner, Hermann [22 ,23 ,24 ]
Arndt, Volker [22 ]
Brauch, Hiltrud [24 ,25 ,26 ]
Bruening, Thomas [27 ]
Mannermaa, Arto [28 ,29 ,30 ]
Kosma, Veli-Matti [31 ,32 ]
Lambrechts, Diether [33 ]
Keupers, Machteld [34 ]
Couch, Fergus J. [35 ]
Vachon, Celine [5 ,6 ]
Giles, Graham G. [5 ,6 ]
MacInnis, Robert J. [5 ,6 ]
Figueroa, Jonine [9 ,36 ]
Brinton, Louise [9 ]
Czene, Kamila [37 ]
Brand, Judith S. [37 ]
Gabrielson, Marike [37 ]
Humphreys, Keith [37 ]
Cox, Angela [38 ]
Cross, Simon S. [39 ]
Dunning, Alison M. [40 ]
Orr, Nick [41 ]
Swerdlow, Anthony [41 ]
Hall, Per [37 ]
Pharoah, Paul D. P. [40 ]
Schmidt, Marjanka K. [11 ,42 ]
Easton, Douglas F. [40 ]
Chatterjee, Nilanjan [9 ,43 ,44 ]
Chang-Claude, Jenny [1 ,45 ]
机构
[1] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
[2] QuintilesIMS, Real World Insights, CESE, Frankfurt, Germany
[3] Sookmyung Womens Univ, Dept Stat, Seoul, South Korea
[4] Inst Canc Res, Div Genet & Epidemiol, London, England
[5] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic, Australia
[6] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia
[7] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England
[8] Cyprus Inst Neurol & Genet, Dept Elect Microscopy Mol Pathol, Nicosia, Cyprus
[9] NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,MSC 9776, Bethesda, MD 20892 USA
[10] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia
[11] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp, Div Mol Pathol, Amsterdam, Netherlands
[12] Friedrich Alexander Univ Erlangen Nuremberg, Comprehens Canc Ctr Erlangen EMN, Univ Hosp Erlangen, Dept Gynaecol & Obstet, Erlangen, Germany
[13] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[14] Complejo Hosp Univ Santiago, Inst Invest Sanitaria Santiago, Genom Med Grp, IDIS,Galician Fdn Genom Med, Santiago De Compostela, Spain
[15] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[16] Complejo Hosp Univ Vigo, Inst Investigac Sanitaria Galicia, Oncol & Genet Unit, Vigo, Spain
[17] Univ Paris Sud, Univ Paris Saclay, Ctr Res Epidemiol & Populat Hlth, Villejuif, France
[18] Copenhagen Gen Populat Study, Copenhagen, Denmark
[19] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark
[20] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[21] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Breast Surg, Herlev, Denmark
[22] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[23] German Canc Res Ctr, Div Prevent Oncol, Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[24] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany
[25] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[26] Univ Tubingen, Dept Clin Pharmacol, Tubingen, Germany
[27] Inst Ruhr Univ Bochum, German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany
[28] Univ Eastern Finland, Translat Canc Res Area, Kuopio, Finland
[29] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland
[30] Kuopio Univ Hosp, Dept Clin Pathol, Kuopio, Finland
[31] VIB Ctr Canc Biol, Leuven, Belgium
[32] Univ Leuven, Lab Translat Genet, Leuven, Belgium
[33] Univ Hosp Leuven, Dept Radiat Oncol, Leuven, Belgium
[34] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[35] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[36] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland
[37] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[38] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England
[39] Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England
[40] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England
[41] Inst Canc Res, Div Breast Canc Res, London, England
[42] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[43] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[44] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA
[45] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hamburg, Germany
关键词
Breast cancer; genetic susceptibility; gene-environment interactions; risk prediction; epidemiology; SUSCEPTIBILITY LOCI; TUMOR SUBTYPES; PREDICTION; MODELS;
D O I
10.1093/ije/dyx242
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Polygenic risk scores (PRS) for breast cancer can be used to stratify the population into groups at substantially different levels of risk. Combining PRS and environmental risk factors will improve risk prediction; however, integrating PRS into risk prediction models requires evaluation of their joint association with known environmental risk factors. Methods: Analyses were based on data from 20 studies; datasets analysed ranged from 3453 to 23 104 invasive breast cancer cases and similar numbers of controls, depending on the analysed environmental risk factor. We evaluated joint associations of a 77-single nucleotide polymorphism (SNP) PRS with reproductive history, alcohol consumption, menopausal hormone therapy (MHT), height and body mass index (BMI). We tested the null hypothesis of multiplicative joint associations for PRS and each of the environmental factors, and performed global and tail-based goodness-of-fit tests in logistic regression models. The outcomes were breast cancer overall and by estrogen receptor (ER) status. Results: The strongest evidence for a non-multiplicative joint associations with the 77-SNP PRS was for alcohol consumption (P-interaction = 0.009), adult height (P-interaction = 0.025) and current use of combined MHT (P-interaction = 0.038) in ER-positive disease. Risk associations for these factors by percentiles of PRS did not follow a clear dose-response. In addition, global and tail-based goodness of fit tests showed little evidence for departures from a multiplicative risk model, with alcohol consumption showing the strongest evidence for ER-positive disease (P = 0.013 for global and 0.18 for tail-based tests). Conclusions: The combined effects of the 77-SNP PRS and environmental risk factors for breast cancer are generally well described by a multiplicative model. Larger studies are required to confirm possible departures from the multiplicative model for individual risk factors, and assess models specific for ER-negative disease.
引用
收藏
页码:526 / 536
页数:11
相关论文
共 50 条
  • [31] Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk
    Hughes, Elisha
    Tshiaba, Placede
    Gallagher, Shannon
    Wagner, Susanne
    Judkins, Thaddeus
    Roa, Benjamin
    Rosenthal, Eric
    Domchek, Susan
    Garber, Judy
    Lancaster, Johnathan
    Weitzel, Jeffrey
    Kurian, Allison W.
    Lanchbury, Jerry S.
    Gutin, Alexander
    Robson, Mark
    JCO PRECISION ONCOLOGY, 2020, 4 : 585 - 592
  • [32] Toward more personalized breast cancer risk assessment: The polygenic risk score
    Sarkis-Tannous, Daad
    Sukol, Roxanne B.
    Sullivan, Erika
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (10): : 37 - 40
  • [33] Utilizing polygenic risk score for breast cancer risk prediction in a Taiwanese population
    Lin, Yi-Hsuan
    Hung, Chih-Chiang
    Lin, Guan-Cheng
    Tsai, I. -Chen
    Lum, Chih Yean
    Hsiao, Tzu-Hung
    CANCER EPIDEMIOLOGY, 2025, 94
  • [34] Associations between the 313-SNP polygenic risk score and breast cancer risk in women from Crete
    Yiangou, K.
    Hadjisavvas, A.
    Agelaki, S.
    Aggouraki, D.
    Androulakis, N.
    Bozionelou, V.
    Drositis, I.
    Kalmpakis, K.
    Kalykaki, A.
    Kontopodis, E.
    Kotsakis, A.
    Politaki, E.
    Saloustrou, G.
    Vamvakas, L.
    Vardakis, N. K.
    Georgoulias, V.
    Mavroudis, D.
    Michailidou, K.
    Saloustros, E.
    ANNALS OF ONCOLOGY, 2022, 33 : S189 - S189
  • [35] Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
    Morra, Anna
    Jung, Audrey Y.
    Behrens, Sabine
    Keeman, Renske
    Ahearn, Thomas U.
    Anton-Culver, Hoda
    Arndt, Volker
    Augustinsson, Annelie
    Auvinen, Paivi K.
    Freeman, Laura E. Beane
    Becher, Heiko
    Beckmann, Matthias W.
    Blomqvist, Carl
    Bojesen, Stig E.
    Bolla, Manjeet K.
    Brenner, Hermann
    Briceno, Ignacio
    Brucker, Sara Y.
    Camp, Nicola J.
    Campa, Daniele
    Canzian, Federico
    Castelao, Jose E.
    Chanock, Stephen J.
    Choi, Ji-Yeob
    Clarke, Christine L.
    Couch, Fergus J.
    Cox, Angela
    Cross, Simon S.
    Czene, Kamila
    Dork, Thilo
    Dunning, Alison M.
    Dwek, Miriam
    Easton, Douglas F.
    Eccles, Diana M.
    Egan, Kathleen M.
    Evans, D. Gareth
    Fasching, Peter A.
    Flyger, Henrik
    Gago-Dominguez, Manuela
    Gapstur, Susan M.
    Garcia-Saenz, Jose A.
    Gaudet, Mia M.
    Giles, Graham G.
    Grip, Mervi
    Guenel, Pascal
    Haiman, Christopher A.
    Hakansson, Niclas
    Hall, Per
    Hamann, Ute
    Han, Sileny N.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (04) : 623 - 642
  • [36] Interactions of a polygenic risk score and modifiable lifestyle factors for breast cancer in the Multiethnic Cohort
    Chou, Alisha
    Chen, Fei
    Wan, Peggy
    Sheng, Xin
    Park, Song-Yi
    Stram, Daniel O.
    Wilkens, Lynne R.
    Le Marchand, Loic
    Haiman, Christopher A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (01) : 300 - 301
  • [37] Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score
    Gao, Chi
    Polley, Eric C.
    Hart, Steven N.
    Huang, Hongyan
    Hu, Chunling
    Gnanaolivu, Rohan
    Lilyquist, Jenna
    Boddicker, Nicholas J.
    Na, Jie
    Ambrosone, Christine B.
    Auer, Paul L.
    Bernstein, Leslie
    Burnside, Elizabeth S.
    Eliassen, A. Heather
    Gaudet, Mia M.
    Haiman, Christopher
    Hunter, David J.
    Jacobs, Eric J.
    John, Esther M.
    Lindstrom, Sara
    Ma, Huiyan
    Neuhausen, Susan L.
    Newcomb, Polly A.
    O'Brien, Katie M.
    Olson, Janet E.
    Ong, Irene M.
    Patel, Alpa, V
    Palmer, Julie R.
    Sandler, Dale P.
    Tamimi, Rulla
    Taylor, Jack A.
    Teras, Lauren R.
    Trentham-Dietz, Amy
    Vachon, Celine M.
    Weinberg, Clarice R.
    Yao, Song
    Weitzel, Jeffrey N.
    Goldgar, David E.
    Domchek, Susan M.
    Nathanson, Katherine L.
    Couch, Fergus J.
    Kraft, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (23) : 2564 - +
  • [38] Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium
    Gaudet, Mia M.
    Milne, Roger L.
    Cox, Angela
    Camp, Nicola J.
    Goode, Ellen L.
    Humphreys, Manjeet K.
    Dunning, Alison M.
    Morrison, Jonathan
    Giles, Graham G.
    Severi, Gianluca
    Baglietto, Laura
    English, Dallas R.
    Couch, Fergus J.
    Olson, Janet E.
    Wang, Xianshu
    Chang-Claude, Jenny
    Flesch-Janys, Dieter
    Abbas, Sascha
    Salazar, Ramona
    Mannermaa, Arto
    Kataja, Vesa
    Kosma, Veli-Matti
    Lindblom, Annika
    Margolin, Sara
    Heikkinen, Tuomas
    Kampjarvi, Kati
    Aaltonen, Kirsimari
    Nevanlinna, Heli
    Bogdanova, Natalia
    Coinac, Irina
    Schuermann, Peter
    Doerk, Thilo
    Bartram, Claus R.
    Schmutzler, Rita K.
    Tchatchou, Sandrine
    Burwinkel, Barbara
    Brauch, Hiltrud
    Torres, Diana
    Hamann, Ute
    Justenhoven, Christina
    Ribas, Gloria
    Arias, Jose I.
    Benitez, Javier
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Flyger, Henrik L.
    Peto, Julian
    Fletcher, Olivia
    Johnson, Nichola
    Silva, Isabel dos Santos
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (05) : 1610 - 1616
  • [39] Association of polygenic risk scores with breast cancer risk among women with benign breast disease
    Winham, Stacey J.
    Sherman, Mark
    Vierkant, Robert
    McCauley, Bryan
    Scott, Christopher
    Gaudet, Mia
    Troester, Melissa
    Pruthi, Sandhya
    Radisky, Derek
    Degnim, Amy
    Aronson, Kristan
    Murphy, Rachel
    Guenel, Pascal
    Truong, Therese
    Chang-Claude, Jenny
    Becher, Heiko
    Garcia-Closas, Montserrat
    Chanock, Stephen
    Ahearn, Thomas
    Yang, Xiaohong
    Easton, Doug
    Bolla, Manjeet
    Vachon, Celine
    CANCER RESEARCH, 2023, 83 (07)
  • [40] Polygenic Risk Scores in Breast Cancer
    Mina, Lida A.
    Arun, Banu
    CURRENT BREAST CANCER REPORTS, 2019, 11 (03) : 117 - 122